Skip to main content
Ira Goldberg, MD, Endocrinology, New York, NY, NYU Langone Hospitals

IraJayGoldbergMD

Endocrinology New York, NY

Diabetes, Lipid Metabolism

Director, Division of Endocrinology, Diabetes, and Metabolism

Overview of Dr. Goldberg

Dr. Ira Goldberg, MD is an endocrinologist in New York, New York. He is currently licensed to practice medicine in New York. He is affiliated with NYU Langone Hospitals.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
  • Harvard Medical School
    Harvard Medical SchoolClass of 1975
  • Massachusetts Institute of TechnologyB.S., 1971

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Member Association of American Physicians, 1999
  • Merck Frost Visiting Professor McGill University, 2009
  • Richard Lewar Centre of Excellence in Cardiovascular Research, Distinguished Visiting Professor University of Toronto, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?  
    Heinecke JW, Goldberg IJ, Diabetes, 1/1/2014
  • Cardiac Metabolic Compensation to Hypertension Requires Lipoprotein Lipase  
    Yamashita H, KG. Bharadwaj, S Ikeda, T-S Park, IJ Goldberg, A J Physio, Endo/Metab, 1/1/2008
  • In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation  
    Takahashi M, M Yokoyama, Y Hiyama, Y Hu, K Melford, A Bensadoun, IJ Goldberg, ATVB, 1/1/2008
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Diabetes and Hypertriglyceridemia: Cardiovascular Risk, Mechanisms, and Indications for Treatment 
    ENDO 2019 - New Orleans, LA - 3/26/2019
  • Hepatic Substrate Metabolism and Cardiometabolic Disease 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
  • Endocrinology Board Review, Endocrinology Society 
    San Francisco - 9/2/2014
  • Join now to see all

Press Mentions

  • ATVB Named Lecture Reviews—Insight into Author
    ATVB Named Lecture Reviews—Insight into AuthorMarch 21st, 2018
  • Arrowhead Pharmaceuticals Hosts R&D Day on Emerging Pipeline of RNAi Therapeutics
    Arrowhead Pharmaceuticals Hosts R&D Day on Emerging Pipeline of RNAi TherapeuticsOctober 18th, 2019
  • Protecting the Heart Health of Diabetic Patients
    Protecting the Heart Health of Diabetic PatientsMay 7th, 2013
  • Join now to see all

Grant Support

  • Diabetes-Mediated Effects On Myeloid Precursors And Vascular ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2012
  • Nutritional And Hormonal Pathways For Reduction Of Apob-LipoproteinsNational Heart, Lung, And Blood Institute2012
  • Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2010–2011
  • Hyperglycemia, Aldose Reductase And Murine AtherosclerosisNational Heart, Lung, And Blood Institute2006–2010
  • Creating Glucose Responsive Cardiovascular ComplicationsNational Heart, Lung, And Blood Institute2006–2010
  • Mechanisms Of Fatty Acid Uptake By Cardiac MuscleNational Heart, Lung, And Blood Institute2003–2010
  • Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2000–2009
  • Role Of Leptin In Atherosclerosis And Arterial InjuryNational Heart, Lung, And Blood Institute2006–2007
  • Vascular Effects Of Heparan Sulfate ProteoglycansNational Heart, Lung, And Blood Institute2002–2006
  • Hyperglycemia, Aldose Reducatse &Murine AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005
  • Atherogenicity Of APOB Containing LipoproteinsNational Heart, Lung, And Blood Institute1999–2003
  • Lipolysis, Lipoprotein Lipase And AtherogenesisNational Heart, Lung, And Blood Institute1997–2001
  • Extracellular Regulation Of Lipoprotein LipaseNational Heart, Lung, And Blood Institute1995–1999
  • Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute1991–1994

Hospital Affiliations